What is DNA Data Storage from Biomemory?

DNA Data Storage translates binary digital content into synthetic DNA strands. Binary data is converted into a molecular code, corresponding DNA strands are then synthesized, physically stored into a container (DNA Card), and later read, using available DNA-reading technologies. Biomemory industrializes this process into rackable storage servers designed for data center environments.

Why use DNA instead of a traditional storage media?

As data volumes scale, traditional architectures face structural physical, economic, and environmental limits. DNA introduces a new storage tier designed for long-term scalability. DNA has been selected as the molecule of choice for cold storage applications, for many combined reasons: very stable molecule, especially in its double-helix form; broad knowledge base and availability of massive characterization data; strong global trust in stability, reliability and longevity, in line with cold storage IT requirements; availability of DNA reading commercial equipment, currently and as long as human DNA shall be read; ability to replicate DNA with a very low error rate, including using living organisms (e.g. bacterias) for low-cost high-volume production.

How durable is the DNA used for Data Storage?

DNA is inherently stable over extremely long periods. Millenia can be reached under very cold and hermetic special conditions. However, for IT-related applications, a retention and readability assurance of 50, 100 or 150 years is good enough. Biomemory is aligning with these market requirements and the enterprise-grade resilience levels, to offer the best cost & data accessibility trade-off. Along the specified life-time, DNA is stable and does not need to be refreshed or remastered, unlike other magnetic or electronics data storage media.

Is Biomemory DNA safe?

Yes. Biomemory uses fully synthetic, biosecure DNA blocks designed to prevent biological interaction, and compliant with the most stringent biosecurity regulation or recommendation. Our DNA, by design, cannot express proteins or interact with living systems. Biosafety is embedded by design at the molecular level, and validated by independent third party compliance testing.

How does DNA Data Storage integrate with existing IT infrastructure?

DNA Data Storage is designed as a new data storage tier within standard multi-tier architectures. Our storage servers interface with existing data center environments through interoperable APIs, enabling seamless integration alongside traditional storage technologies. Biomemory is using the S3 de-facto standard interface for object storage systems, originally developed by AWS, and now Open Source.

Is DNA Data Storage cost-effective?

DNA enables structurally lower long-term total cost of ownership. Ultra-low energy consumption at rest, elimination of frequent hardware refresh cycles, and biologically manufactured consumables reduce both operational and capital expenditures (CapEx) over time. Biomemory has developed a roadmap towards a very low operational cost (OpEx) with low-cost consumables and high-level of automation, along with affordable CapEx compatible enterprise budget, and cloud-providers profitability.

What types of data are best suited for DNA Data Storage?

DNA Data Storage is optimized for high-value, long-term, cold data. Typical use cases include archival preservation, regulated datasets, AI training data sets, compliance records, and critical backups requiring durability and integrity over decades.

Is Biomemory DNA Data Storage only about storage?

Data storage is the primary application target of Biomemory, but cybersecurity augmentation is also strong a focus. As the technology matures, molecular systems will also offer unique properties for parallelism and programmability. Over time, this opens pathways toward molecular-scale search and compute capabilities, extending performance beyond traditional microelectronic architectures.

Molecular IT, industrialized

Biomemory is industrializing DNA as a new information tier: Molecular IT.

Our solutions

Some information has to outlive the system that created it

Storage is specializing, and DNA is among the densest, most durable, and most sovereign of the emerging media now crossing from the laboratory into commercial products. Some records outlive the institutions and systems that made them, and the value they carry is trust over time, not capacity. Biomemory enters through sovereign data protection and trust preservation today, and expands into storage and compute.

Who we are

Biomemory is industrializing DNA as a new information tier : Molecular IT.

Data is stored in synthetic DNA and, increasingly, searched and computed on. Spun out of Sorbonne University and CNRS, we own the full stack, from molecular biology to enterprise software, with industrial production in Paris and, following the Catalog acquisition, in Boston. We are a leader in commercial DNA data storage and co-chair of the DNA Data Storage Alliance. We enter the market through sovereign data protection and trust preservation, and expand into storage, with molecular search and compute beyond it.

Density statement

As a storage medium, DNA holds on the order of one million times more data per unit volume than physical data storage. That is a property of the molecule, not a product specification, and it is why DNA is worth industrializing

Sources : www.science.org, www.nature.com, www.giving.columbia.edu

Our story

Beyond silicon

2021 - From research to reality

Biomemory spins out of CNRS and Sorbonne University, building on years of academic research. Its technology is demonstrated through a landmark project: storing the French Declaration of the Rights of Man and of the Citizen and the Declaration of the Rights of Woman in DNA, with copies preserved by the French National Archives.

2024 - €18M to turn technology into products

Biomemory raises €18 million from Bpifrance, Crédit Mutuel Innovation, Blast and other investors. The funding accelerates technology development and, critically, its productization, turning scientific breakthroughs into deployable DNA Data Storage solutions and enabling the company to engage its first customers.

March 2026 - Scaling up with Catalog’s technology and expertise

Biomemory acquires key assets from Catalog, significantly expanding its capabilities and intellectual property portfolio to more than 90 patents. The acquisition also brings world-class DNA Data Storage experts into the team and establishes a production and R&D footprint in Boston, alongside its Paris operations.

June 2026 - Opening a new route to enterprise customers

Biomemory signs its first partnership with a cloud and data storage provider, Scality. The collaboration creates an additional route into enterprise IT environments, complementing Biomemory’s direct sales model and paving the way for DNA Data Storage to integrate with existing storage infrastructures.

Our vision

Molecular storage extends silicon, it does not replace it

Global data creation is exploding. Only 30% of the world’s data is durably stored. Data centers already consume around 2% of global electricity. As volumes double every few years, the silicon-based storage model is reaching structural limits.

DNA introduces a fundamentally different data storage paradigm. By combining molecular stability with modular, data center-compatible system architecture, it enables a new storage tier optimized for extreme density, long-term readability, and structural energy efficiency.

Molecular storage does not replace silicon. It extends it. The data centers of the future will integrate electronic and molecular layers, each designed for its optimal role. DNA becomes the ultra-durable, ultra-dense foundation within a multi-tier infrastructure.

DNA Data Storage is the first industrial step toward molecular Information Systems, where preservation, search, and computation ultimately converge.

Locations

Europe and North America

Paris

Headquarters and DNA production

5 impasse Reille, 75014 Paris, France

Boston

Production and research

529 Main Street, Suite 125 (AKA 1025), Charlestown, MA 02129 USA